Opus Genetics (IRD) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.43% |
| Dec 31, 2025 | -59.70% |
| Sep 30, 2025 | 40.04% |
| Jun 30, 2025 | -14.18% |
| Mar 31, 2025 | -20.92% |
| Dec 31, 2024 | -44.99% |
| Sep 30, 2024 | 29.65% |
| Jun 30, 2024 | -27.57% |
| Mar 31, 2024 | -225.68% |
| Dec 31, 2023 | 251.45% |
| Sep 30, 2023 | -403.64% |
| Jun 30, 2023 | 127.13% |
| Mar 31, 2023 | -112.66% |
| Dec 31, 2022 | 740.08% |
| Sep 30, 2022 | -18.09% |
| Jun 30, 2022 | 38.27% |
| Mar 31, 2022 | -9.28% |
| Dec 31, 2021 | -57.53% |
| Sep 30, 2021 | 17.19% |
| Jun 30, 2021 | 25.53% |
| Mar 31, 2021 | -33.36% |
| Dec 31, 2020 | -312.69% |
| Sep 30, 2020 | -62.21% |
| Jun 30, 2020 | 11.07% |
| Mar 31, 2020 | -114.72% |
| Dec 31, 2019 | 309.07% |
| Sep 30, 2019 | -31.63% |
| Jun 30, 2019 | 58.76% |
| Mar 31, 2019 | 5.20% |
| Dec 31, 2018 | -10.88% |
| Sep 30, 2018 | 6.42% |
| Jun 30, 2018 | 20.46% |
| Mar 31, 2018 | -51.10% |
| Dec 31, 2017 | -7.48% |
| Sep 30, 2017 | 15.91% |
| Jun 30, 2017 | 1.67% |
| Mar 31, 2017 | -179.15% |
| Dec 31, 2016 | 52.16% |
| Sep 30, 2016 | 38.35% |
| Jun 30, 2016 | -42.63% |
| Mar 31, 2016 | 19.47% |
| Dec 31, 2015 | 2.10% |
| Sep 30, 2015 | -2.26% |
| Jun 30, 2015 | -9.01% |
| Mar 31, 2015 | -38.70% |
| Dec 31, 2014 | -11.92% |
| Sep 30, 2014 | 11.84% |
| Jun 30, 2014 | -14.54% |
| Mar 31, 2014 | -14.57% |
| Dec 31, 2013 | -33.81% |
| Sep 30, 2013 | 32.87% |
| Jun 30, 2013 | -61.37% |
| Mar 31, 2013 | -44.53% |
| Dec 31, 2012 | 34.93% |
| Sep 30, 2012 | 16.68% |
| Jun 30, 2012 | -3.31% |
| Mar 31, 2012 | 60.72% |
| Dec 31, 2011 | -54.34% |
| Sep 30, 2011 | 37.59% |
| Jun 30, 2011 | -108.78% |
| Mar 31, 2011 | -0.25% |
| Dec 31, 2010 | -52.26% |